What is the revenue and EPS growth rate for Prudential year over year?

What does Prudential do and what are its main business segments?

Did Prudential beat or miss consensus estimates last quarter?

What is Prudential's gross profit margin?

What were the key takeaways from Prudential's earnings call?

What factors drove the changes in Prudential's revenue and profit?

What is the market's earnings forecast for Prudential next quarter?

What is Prudential's latest dividend and current dividend yield?

- **Double-Digit Growth**: 12% increase in new business profit and operating profit per share, driven by strong execution across core markets.
- **$5B Capital Return Plan**: 2024-2027 total returns include $2B buyback by end-2025 and recurring buybacks starting 2026.
- **Margin Expansion**: 2.3ppt improvement to 38.2% from repricing, scale, and product mix; further gains expected through 2027.
- **Strategic Investments**: $400M spent on tech modernization, customer engagement, and operational efficiency.
- **Market Momentum**: 16% growth in Hong Kong, 34% in Indonesia, and 45% agency recruitment in China.

**【CEO Summary Section】**
- Delivered double-digit growth across key financial metrics in H1 2025, including 12% growth in new business profit and adjusted operating profit per share.
- Announced a capital management update, planning to return over $5 billion to shareholders between 2024 and 2027, including $2 billion share buyback by end-2025.
- Invested $400 million in strategic initiatives to modernize technology, enhance customer engagement, and accelerate platform improvements.
- Highlighted strong momentum in core markets: 16% growth in Hong Kong and 34% in Indonesia, driven by agency and bancassurance channels.
- Set to achieve 2027 financial objectives, with focus on high-quality new business and operational efficiency.

**【CFO Financial Commentary】**
- GAAP net income of $420 million; Non-GAAP EPS of $1.08, exceeding expectations.
- Gross operating free surplus generation up 14% YoY, net OFSG up 20%.
- Updated capital allocation framework: ordinary dividend growth >10% annually from 2025-2027, plus $500M buyback in 2026 and $600M return in 2027.
- New business profit margin expanded 2.3ppt to 38.2%, driven by repricing and product mix improvements.
- In-force management variances improving, targeting return to historic positive levels by 2027.

**【Q&A Highlights】**
- **Agency Performance**: China agency recruitment up 45%, active agents +6%; Hong Kong agency NBP per agent +4%. Focus on quality recruitment, MDRT growth, and digital capabilities.
- **Capital Returns**: $5B+ total returns 2024-2027, excluding potential India AMCo IPO proceeds. Buyback sustainability driven by OFSG growth and 70% remittance policy.
- **Margins**: 2.3ppt margin expansion from repricing, scale leverage, and health/agency mix. Target further improvements through 2027.
- **Regulatory Impact**: China regulatory changes align with quality focus, supporting agent retention and income spread.
- **Variances**: Core operating variances improving, targeting pre-COVID positive levels by 2027.

Prudential plc (PUK) Q2 2025 Earnings Call Transcript

- **2024 Growth Milestones**: 11% NBP growth, 8% EPS expansion, and $2.6 billion free surplus generation. 
- **2025 Inflection Point**: Free surplus to grow 19% CAGR to $4.4 billion by 2027, driven by quality new business and cost control. 
- **India Health Expansion**: JV with HCL to build standalone health insurer, with modest capital allocation. 
- **China Transformation**: 40% of Q4 2024 new business in par savings, up from 5% in 2023. 
- **Capital Returns**: $2 billion buyback completed in 2025, with dividend growth tied to free surplus trajectory.

**【CEO Summary Section】**
- **2024 Performance Highlights**: New business profit grew 11% to $3.1 billion, adjusted operating profit per share rose 8%, and gross operating free surplus generation reached $2.6 billion. 
- **Strategic Focus**: Accelerated growth through quality new business, in-force book management, and health insurance expansion. Launched a joint venture in India with HCL Group to build a standalone health insurance business.
- **Capital Allocation**: Dividends per share increased 13%, and a $2 billion share buyback program (8% of outstanding stock) was completed ahead of schedule in 2025. 
- **2025 Outlook**: Inflection point for free surplus growth with pro forma ratio near the upper end of guidance. Exploring listing of Indian asset management company to return proceeds to shareholders.

**【CFO Financial Commentary】**
- **2025 Guidance**: All key metrics (new business profit, operating EPS, free surplus, dividends) expected to grow >10%. 
- **Free Surplus Growth**: 2025 gross OFSG up 13% to $2.7 billion, with 2027 target of $4.4 billion achievable through organic growth and cost control. 
- **Cost Management**: Operating expenses reduced 5% YoY, with focus on central cost containment and medical claims efficiency. 
- **Tax Rate**: Effective tax rate stable at ~17%, with no material impact from BEPS regulations.

**【Q&A Key Themes】**
- **Free Surplus Growth Drivers**: Improved cash signature of new business cohorts (+36% YoY), cost containment, and repricing tailwinds. 
- **India JV Investment**: Modest outlay fully within existing capital plans; focus on organic growth and customer experience. 
- **Hong Kong Regulatory Impact**: Neutral impact on business due to disciplined product mix and agency focus. 
- **China Strategy**: Transition to par savings products (40% of Q4 2024 new business) and protection mix growth. 
- **Capital Priorities**: Total shareholder returns (dividends, buybacks, asset monetization) over inorganic growth.

Actual														1.42
Forecast														1.42
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Actual	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Forecast	--	--	--	--	--	--	--	--	--	--	--	--	--	0
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

PUK

PUK fundamentals

PUK Q4 2025 Earnings

Earnings Call

You can ask Aime

PUK

PUK fundamentals

PUK Q4 2025 Earnings

Earnings Call

PUK Earnings Call Summary for Q4/2025 Mar 26, 2026

PUK Earnings Call Summary for Q3/2025 Mar 26, 2026

PUK Earnings Call Summary for Q2/2025Invalid Date on Aug 27, 2025

PUK Earnings Call Summary for Q4/202410:00 AM on Mar 20, 2025

PUK Earnings Call Summary for Q2/2024 Mar 26, 2026

You can ask Aime